We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00329212
First Posted: May 24, 2006
Last Update Posted: November 15, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Committee on Chinese Medicine and Pharmacy
  Purpose
The purpose of this study is to investigate the pharmacokinetics in humans of San Huang Xie Jin Tang (SHXJT) and evaluate the bioequivalence between herbal concentrate and traditional decoction.

Condition Intervention
Healthy Drug: San Huang Xie Jin Tang

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Bioequivalence of Bioactive Markers Between Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans

Further study details as provided by Committee on Chinese Medicine and Pharmacy:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The volunteers about 6~8 persons should be aged from 20 to 35 years old with a body weight between 50~80 kg, no marriage and have a healthy body condition.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00329212


Locations
China, Taiwan
Committee on Chinese Medicine and Pharmacy, Department of Health
Taipei, Taiwan, China
Sponsors and Collaborators
Committee on Chinese Medicine and Pharmacy
Investigators
Principal Investigator: Y C Hou, Professor School of Chinese Medicine, China Medical University
  More Information

ClinicalTrials.gov Identifier: NCT00329212     History of Changes
Other Study ID Numbers: CCMP95-RD-010
First Submitted: May 23, 2006
First Posted: May 24, 2006
Last Update Posted: November 15, 2006
Last Verified: November 2006

Keywords provided by Committee on Chinese Medicine and Pharmacy:
Pharmacokinetics
Bioavailability
Therapeutic Equivalency